Biotechnology Eli Lilly (LLY) is paving the way to a strong 2021 5 years ago Shares of Eli Lilly & Co. (NYSE: LLY) were up over 2% on Wednesday. The stock has gained over 30%… Veru Inc. (VERU) Q4 2020 Earnings Call Transcript 5 years ago Veru Inc. (NASDAQ: VERU) Q4 2020 earnings call dated Dec. 09, 2020. Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman,… Avid Bioservices, Inc. (CDMO) Q2 2021 Earnings Call Transcript 5 years ago Avid Bioservices, Inc. (NASDAQ: CDMO) Q2 2021 earnings call dated Dec. 02, 2020 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President… Is it time to book profits from Moderna? 5 years ago Moderna (NASDAQ: MRNA) stock has soared a staggering 679% since the beginning of this year. If you did identify the… Alexion’s long-term prospects remain intact amid continued focus on rare diseases 5 years ago Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has stood out in the crowded pharmaceuticals marketplace by developing effective treatments for certain rare health… China Biologic Products Holdings, Inc. (CBPO) Q3 2020 Earnings Call Transcript 5 years ago China Biologic Products Holdings, Inc. (NASDAQ: CBPO) Q3 2020 earnings call dated Nov. 25, 2020. Corporate Participants: Philip Lisio -- Investor Relations,… Is it the right time to invest in Agilent Technologies (A)? 5 years ago Agilent Technologies, Inc. (NYSE: A) ended fiscal 2020 on a positive note, bettering its performance consistently after experiencing a slowdown… Palatin Technologies, Inc. (PTN) Q1 2021 Earnings Call Transcript 5 years ago Palatin Technologies, Inc. (AMEX: PTN) Q1 2021 earnings call dated Nov. 17, 2020 Corporate Participants: Carl Spana -- President and Chief Executive… COVID-19 vaccine: Pfizer (PFE) and Moderna (MRNA) are ahead in the race, where are the others? 5 years ago Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) have made significant progress in their efforts to develop a vaccine… Moderna (MRNA) gains as COVID-19 vaccine candidate shows over 94% efficacy 5 years ago Shares of Moderna Inc. (NASDAQ: MRNA) were up over 8% in morning trade on Monday as the company reported positive… Bio-Path Holdings, Inc. (BPTH) Q3 2020 Earnings Call Transcript 5 years ago Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q3 2020 earnings call dated Nov. 13, 2020 Corporate Participants: Will O'Connor -- Stern Investor Relations Peter… Biocept Inc (BIOC) Q3 2020 Earnings Call 5 years ago Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss -- Investor Relations Michael W. Nall -- President… PDL BioPharma, Inc. (PDLI) Q3 2020 Earnings Call Transcript 5 years ago PDL BioPharma, Inc. (NASDAQ: PDLI) Q3 2020 earnings call dated Nov. 11, 2020 Corporate Participants: Jody Cain -- Senior Vice President, LHA… Biogen (BIIB) might need to revisit pipeline after Alzheimer’s drug setback 5 years ago The controversy surrounding biotechnology firm Biogen's (NASDAQ: BIIB) Alzheimer's drug Aducanumab took a positive turn last week after the FDA… Immunogen Inc (IMGN) Q3 2020 Earnings Call Transcript 5 years ago Immunogen Inc (NASDAQ: IMGN) Q3 2020 earnings call dated Nov. 06, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications… CVS Health Corp. (CVS) Q3 2020 Earnings Call Transcript 5 years ago CVS Health Corp. (NYSE: CVS) Q3 2020 earnings call dated Nov. 06, 2020 Corporate Participants: Valerie C Haertel -- Senior Vice President,… Amarin Corporation plc (AMRN) Q3 2020 Earnings Call Transcript 5 years ago Amarin Corporation plc (NASDAQ: AMRN) Q3 2020 earnings call dated Nov. 05, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director, Investor Relations… McKesson Corp. (MCK) Q2 2021 Earnings Call Transcript 5 years ago McKesson Corp. (NYSE: MCK) Q2 2021 earnings call dated Nov. 03, 2020 Corporate Participants: Holly Weiss -- Senior Vice President, Investor Relations… AbbVie (ABBV) to focus more on pipeline as recovery gathers pace 5 years ago AbbVie, Inc. (NYSE: ABBV) has been recovering steadily from the virus-related slowdown and latest statistics show that the company's performance… Moderna Inc. (MRNA) Q3 2020 Earnings Call Transcript 5 years ago Moderna Inc. (NASDAQ: MRNA) Q3 2020 earnings call dated Oct. 29, 2020 Corporate Participants: Lavina Talukdar -- Senior Vice President & Head… Moderna reports higher earnings, wider loss in Q3 5 years ago Moderna Inc (NASDAQ: MRNA) reported third-quarter 2020 financial results before the opening bell on Thursday. The frontrunner in COVID vaccine… Next» « Previous